Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Robert K. who wrote (7962)	12/7/1998 11:31:00 AM
From: aknahow	Respond to of 17367

Bob, not sure what to do with this. Here you take it. golgi.harvard.edu

To: Robert K. who wrote (7962)	12/7/1998 12:53:00 PM
From: aknahow	Read Replies (1) \| Respond to of 17367

Got my UPS packages. Voted by phone. Easy to do. Can also do it on the internet.

To: Robert K. who wrote (7962)	12/7/1998 1:30:00 PM
From: aknahow	Respond to of 17367

Robert, you should find of interest. Do search for BPI. Also do search again. pctvmag.com . "BPI potently neutralizes LPS of any chemotype, but p15s and defensins are less active against long-chain (S-type) LPS. In whole blood ex vivo, the p15s and NP1 are approximately 1000-fold less potent than BPI," "Thus, BPI stands out for its ability to inhibit isolated or bacterial LPS under physiologic conditions." "Thus, BPI stands out for its ability to inhibit isolated or bacterial LPS under physiologic conditions. However, p15s and defensins may also contribute to supression of endotoxic signaling by Gram-negative bacteria via synergistic (with BPI) growth inhibition upon extracellular release of these proteins from PMN during inflammation"